Establishment of equity investment fund company by Nanjing Pharmaceutical and others

According to the enterprise search app, Nanjing Medicine Group Jiangfeng Equity Investment Fund Co., Ltd. was recently established, with Peng Yuping as its legal representative and a registered capital of 2 billion yuan. Its business scope includes equity investment, engaging in equity investment, investment management, asset management, etc. through private equity funds. Equity penetration shown in the enterprise search app reveals that the company is jointly held by Nanjing Medicine, Nanjing Xingong Medical and Health Chain Mergers and Acquisition Equity Investment Fund Partnership Enterprise.